🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Priya Life Science Medicines register
Registers Clinical trials Drugs API
Registers› Irish medicines
Medicines register · Ireland

Every medicine authorised for the Irish market

The Health Products Regulatory Authority's full list of authorised products — brand, active substance, licence holder, licence number and market status. Filter it, cite it, and take it away as a file.

Download CSV
Source: HPRA open dataset ("Authorised or Transfer Pending Products"), CC BY 4.0. Complete coverage — all 10,336 authorised products are in this register. Synced 20 Sep 2026, 17:51 UTC
Narrow the register Reset
Matches brand name, active substance, licence holder and licence number.
Browse by first letter
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9
182 of 10,336 medicines
Download
Medicine
Active substance
Licence holder
Status
Adjupanrix suspension and emulsion for emulsion for injection. Pandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted) EU/1/09/578/001
Purified antigen fractions of inactivated split virions a/vietnam/1194/2004 nibrg-14 (h5n1)
GlaxoSmithKline Biologicals S.A.
—
Alli EU/1/07/401/12-15
Orlistat
GlaxoSmithKline Dungarvan Limited
—
Alli EU/1/07/401/1-6
Orlistat
GlaxoSmithKline Dungarvan Limited
—
Alli 60 mg hard capsules EU/1/07/401/7-11
Orlistat
GlaxoSmithKline Dungarvan Limited
—
Ambirix suspension for injection in pre-filled syringe Hepatitis A (inactivated) and hepatitis B (rDNA) (HAB) vaccine (adsorbed) EU/1/02/224/005
Hepatitis b surface antigen (hbs ag), Hepatitis a virus
GlaxoSmithKline Biologicals S.A.
—
Ambirix Suspension for injection in pre-filled syringeHepatitis A (inactivated) and hepatitis B (rDNA) (HAB) vaccine (adsorbed) EU/1/02/224/001
Hepatitis b surface antigen (hbs ag), Hepatitis a virus
GlaxoSmithKline Biologicals S.A.
—
Ambirix Suspension for injection in pre-filled syringeHepatitis A (inactivated) and hepatitis B (rDNA) (HAB) vaccine (adsorbed) EU/1/02/224/002
Hepatitis b surface antigen (hbs ag), Hepatitis a virus
GlaxoSmithKline Biologicals S.A.
—
Ambirix, suspension for injection in pre-filled syringeHepatitis A (inactivated) and hepatitis B (rDNA) (HAB) vaccine (adsorbed) EU/1/02/224/003
Hepatitis a virus, Hepatitis b surface antigen (hbs ag)
GlaxoSmithKline Biologicals S.A.
—
Ambirix, suspension for injection in pre-filled syringeHepatitis A (inactivated) and hepatitis B (rDNA) (HAB) vaccine (adsorbed) EU/1/02/224/004
Hepatitis a virus, Hepatitis b surface antigen (hbs ag)
GlaxoSmithKline Biologicals S.A.
—
ANORO ELLIPTA 55 micrograms/22 micrograms inhalation powder, pre-dispensed EU/1/14/898/001-003
Vilanterol trifenatate, Umeclidinium bromide
GlaxoSmithKline Trading Services Limited
—
Arexvy powder and suspension for suspension for injection Respiratory Syncytial Virus (RSV) vaccine (recombinant, adjuvanted) EU/1/23/1740/001-002
Recombinant respiratory syncytial virus pre-fusion F protein, adjuvanted with AS01E
GlaxoSmithKline Biologicals
—
Augmentin 250 mg/125 mg film-coated tablets PA1077/093/007
Amoxicillin, Clavulanic acid
GlaxoSmithKline (Ireland) Limited
Marketed
Augmentin 500 mg/125 mg film-coated tablets PA1077/019/003
Amoxicillin, Clavulanic acid
GlaxoSmithKline (Ireland) Limited
Marketed
Augmentin 875 mg/125 mg film-coated tablets PA1077/019/005
Amoxicillin, Clavulanic acid
GlaxoSmithKline (Ireland) Limited
Marketed
Augmentin Duo Mixed Fruit 400 mg/57 mg/5 ml Powder for Oral Suspension PA1077/019/006
Amoxicillin, Clavulanic acid
GlaxoSmithKline (Ireland) Limited
Marketed
Augmentin Paediatric 125 mg/31.25 mg per 5 ml Powder for Oral Suspension PA1077/093/004
Amoxicillin, Clavulanic acid
GlaxoSmithKline (Ireland) Limited
Marketed
AVAMYS 27.5 micrograms/spray, nasal spray suspension EU/1/07/434/001-003
Fluticasone furoate
GlaxoSmithKline Trading Services Limited
—
Avodart 0.5 mg soft capsules PA1077/104/001
Dutasteride
GlaxoSmithKline (Ireland) Limited
Marketed
Bactroban 2% w/w Nasal Ointment PA1077/094/002
Mupirocin calcium
GlaxoSmithKline (Ireland) Limited
Marketed
Bactroban 2% w/w Ointment PA1077/094/001
Mupirocin
GlaxoSmithKline (Ireland) Limited
Marketed
Becotide Evohaler 100 micrograms, Pressurised Inhalation Solution PA1077/042/007
Beclometasone dipropionate
GlaxoSmithKline (Ireland) Limited
Marketed
Becotide Evohaler 250 micrograms, Pressurised Inhalation Solution PA1077/042/009
Beclometasone dipropionate
GlaxoSmithKline (Ireland) Limited
Marketed
Becotide Evohaler 50 micrograms, Pressurised Inhalation Solution PA1077/042/006
Beclometasone dipropionate
GlaxoSmithKline (Ireland) Limited
Marketed
Benlysta 120 mg powder for concentrate for solution for infusion EU/1/11/700/001-002
Belimumab
GlaxoSmithKline (Ireland) Limited
—
Benlysta 200 mg solution for injection in pre-filled pen EU/1/11/700/003-005
Belimumab
GlaxoSmithKline (Ireland) Limited
—
Benlysta 200 mg solution for injection in pre-filled syringe EU/1/11/700/006-007
Belimumab
GlaxoSmithKline (Ireland) Limited
—
Betnovate Cream 0.1% w/w PA1077/001/001
Betamethasone
GlaxoSmithKline (Ireland) Limited
Marketed
Betnovate Ointment 0.1% w/w PA1077/001/002
Betamethasone valerate
GlaxoSmithKline (Ireland) Limited
Marketed
Betnovate Scalp Application 0.1% w/w Cutaneous Solution PA1077/001/003
Betamethasone
GlaxoSmithKline (Ireland) Limited
Marketed
Bexsero 0.5 ml suspension for injection in pre-filled syringe EU/1/12/812/001-004
Recombinant neisseria meningitidis serogroup b nhba fusion protein, Recombinant neisseria meningitidis serogroup b nada fusion protein, Recombinant neisseria meningitidis serogroup b fhbp fusion protein, Outer rmembrane vesicles (omv)
Glaxosmithkline Vaccines S.r.l.
—
BLENREP 100 mg powder for concentrate for solution for infusion EU/1/25/1948/002
Belantamab Mafodotin
GlaxoSmithKline Trading Services Limited
—
BLENREP 70 mg powder for concentrate for solution for infusion EU/1/25/1948/001
Belantamab Mafodotin
GlaxoSmithKline Trading Services Limited
—
Boostrix suspension for injection in pre-filled syringe Diphtheria, tetanus and pertussis (acellular, component) vaccine (adsorbed, reduced antigen(s) content) PA1077/020/001
Pertactin, Filamentous haemagglutinin, Pertussis toxoid, Tetanus toxoid, Diphtheria toxoid
GlaxoSmithKline (Ireland) Limited
Marketed
Cervarix suspension for injection Human Papillomavirus vaccine [Types 16, 18] (Recombinant, adjuvanted, adsorbed) EU/1/07/419/1-12
Hpv 16 l1 protein, Hpv 18 l1 protein
GlaxoSmithKline Biologicals S.A.
—
Combodart 0.5 mg/ 0.4 mg hard capsules PA1077/118/001
Dutasteride, Tamsulosin hydrochloride
GlaxoSmithKline (Ireland) Limited
Marketed
Dectova 10 mg/mL solution for infusion EU/1/18/1349/001
Zanamivir
GlaxoSmithKline Trading Services Limited
—
Dermovate 0.05% w/w Cream PA1077/005/001
Clobetasol propionate
GlaxoSmithKline (Ireland) Limited
Marketed
Dermovate 0.05% w/w Ointment PA1077/005/002
Clobetasol propionate
GlaxoSmithKline (Ireland) Limited
Marketed
Dermovate Scalp Application 0.05% w/v Cutaneous Solution PA1077/005/003
Clobetasol propionate
GlaxoSmithKline (Ireland) Limited
Marketed
Duac Once Daily 10mg/g + 50mg/g Gel PA1077/120/001
CLINDAMYCIN PHOSPHATE, Benzoyl peroxide hydrous
GlaxoSmithKline (Ireland) Limited
Marketed
Elebrato Ellipta 92 micrograms/55 micrograms/22 micrograms inhalation powder, pre-dispensed EU/1/17/1237/001-003
Fluticasone furoate, Umeclidinium bromide, Vilanterol trifenatate
GlaxoSmithKline Trading Services Limited
—
Engerix B 20 micrograms/1 ml Suspension for injection in pre-filled syringe Hepatitis B (rDNA) vaccine (adsorbed) (HBV) PA1077/023/002
Hepatitis b surface antigen, recominant
GlaxoSmithKline (Ireland) Limited
Marketed
Eumovate Cream 0.05% w/w PA1077/006/001
CLOBETASONE BUTYRATE
GlaxoSmithKline (Ireland) Limited
Marketed
EXDENSUR 100 mg solution for injection in pre-filled pen EU/1/25/2007/001
Depemokimab
GlaxoSmithKline Trading Services Limited
—
EXDENSUR 100 mg solution for injection in pre-filled syringe EU/1/25/2007/002
Depemokimab
GlaxoSmithKline Trading Services Limited
—
Fendrix suspension for injection EU/1/04/0299/001-003
Hepatitis b vaccine
GlaxoSmithKline Biologicals S.A.
—
Flixotide Diskus 100 micrograms, Inhalation Powder, pre-dispensed PA1077/044/010
Fluticasone propionate
GlaxoSmithKline (Ireland) Limited
Marketed
Flixotide Diskus 250 micrograms, Inhalation Powder, pre-dispensed PA1077/044/011
Fluticasone propionate
GlaxoSmithKline (Ireland) Limited
Marketed
Flixotide Diskus 50 micrograms, Inhalation Powder, pre-dispensed PA1077/044/009
Fluticasone propionate
GlaxoSmithKline (Ireland) Limited
Marketed
Flixotide Diskus 500 micrograms, Inhalation Powder, pre-dispensed PA1077/044/012
Fluticasone propionate
GlaxoSmithKline (Ireland) Limited
Marketed
Showing 1–50 of 182
1 2 3 Next
Cite this view

Priya Life Science (2026). Irish Medicines Register, filtered. Derived from the HPRA open dataset. Retrieved 28 September 2026. https://priyalifescience.com/medicines

Download this register
GET /api/export.php?register=medicines-ie&format=csv Try the JSON export →
Regulatory information only — not medical advice. For the authoritative record see the HPRA register directly.